EntityWire

EntityWire / EIN 13-1933825

Tax-exempt organization

CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION

EIN 13-1933825. What DOL Form 5500 filings (EFAST2), DOL Form 5500-SF filings (EFAST2) and IRS Exempt Organizations Business Master File say about this entity, with the source and date on every fact. Latest record 2026-09.

Tax-exempt organization ยท Files a Form 5500

CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION

1 EXCHANGE PLZ STE 302, NEW YORK, NY 10006-3720

EIN

13-1933825

Tax-exempt status

501(c)(3) charitable, religious, educational

IRS · 2026-09

Deductibility

Contributions are deductible

IRS · 2026-09

Foundation classification

Publicly supported charity (170(b)(1)(A)(vi))

IRS · 2026-09

IRS ruling date

1947-06

IRS · 2026-09

NTEE code

E120

IRS · 2026-09

Latest tax period on file

2025-06

IRS · 2026-09

Revenue (latest 990)

$54,683,607

IRS · 2026-09

Assets (latest 990)

$170,380,475

IRS · 2026-09

Benefit plan 3, 2024 filing

CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION

DOL · 2026-04-02

Participants (start of year)

11

DOL · 2026-04-02

Plan features

403(b)(1) annuity

DOL · 2026-04-02

Plan type

Single-employer plan

DOL · 2026-04-02

Business code (NAICS)

813000

DOL · 2026-04-02

Benefit plan 4, 2024 filing

CANCER RESEARCH FUND OF THE DAMON RUNYON - WALTER WINCHELL FOUNDATION 403(B) PLAN

DOL · 2025-07-30

What this record is

Public federal filings that carry this EIN, shown as filed. Nothing here is scraped from the IRS and nothing is inferred.

What it is not

Registry status, formation date, and registered agent come from the New York Department of State, Division of Corporations; search the New York registry.

If something is wrong

A name, address, or classification here is what the source published. To correct the source, file with it; to have this page removed, see corrections and removal.

Look up another business

Free. Federal filings and state registries, stamped with their source and date.